×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CTNM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/24
04:05 pm
ctnm
Contineum Therapeutics to Attend the 8th Annual Evercore Healthcare Conference
Medium
Report
Contineum Therapeutics to Attend the 8th Annual Evercore Healthcare Conference
11/24
09:44 am
ctnm
Contineum Therapeutics (NASDAQ:CTNM) had its price target lowered by analysts at Robert W. Baird from $16.00 to $14.00. They now have an "outperform" rating on the stock.
Low
Report
Contineum Therapeutics (NASDAQ:CTNM) had its price target lowered by analysts at Robert W. Baird from $16.00 to $14.00. They now have an "outperform" rating on the stock.
11/21
09:47 am
ctnm
Contineum Therapeutics (NASDAQ:CTNM) had its price target lowered by analysts at Royal Bank Of Canada from $25.00 to $22.00. They now have an "outperform" rating on the stock.
Low
Report
Contineum Therapeutics (NASDAQ:CTNM) had its price target lowered by analysts at Royal Bank Of Canada from $25.00 to $22.00. They now have an "outperform" rating on the stock.
11/21
09:19 am
ctnm
Contineum falls after missing main goals in multiple sclerosis trial [Seeking Alpha]
Low
Report
Contineum falls after missing main goals in multiple sclerosis trial [Seeking Alpha]
11/20
04:30 pm
ctnm
Contineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) [Yahoo! Finance]
High
Report
Contineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) [Yahoo! Finance]
11/20
04:05 pm
ctnm
Contineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
High
Report
Contineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
11/13
09:53 am
ctnm
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock.
Medium
Report
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
5/14/2025
04:05 pm
ctnm
contineum therapeutics, inc. - common stock
MISS
Report
2.6%
contineum therapeutics, inc. - common stock
3/6/2025
04:05 pm
ctnm
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
3/6/2025
04:05 pm
ctnm
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
3/6/2025
04:05 pm
ctnm
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
04:08 pm
ctnm
Form 8-K Contineum Therapeutics, For: Nov 20
High
Report
Form 8-K Contineum Therapeutics, For: Nov 20
11/4
10:39 am
ctnm
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: FRANKLIN RESOURCES INC
Low
Report
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: FRANKLIN RESOURCES INC
10/30
04:13 pm
ctnm
Form 10-Q Contineum Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Contineum Therapeutics, For: Sep 30
10/30
04:09 pm
ctnm
Form 8-K Contineum Therapeutics, For: Oct 30
Medium
Report
Form 8-K Contineum Therapeutics, For: Oct 30
9/18
08:16 am
ctnm
Form 8-K Contineum Therapeutics, For: Sep 18
Low
Report
Form 8-K Contineum Therapeutics, For: Sep 18
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: